Moderna COVID-19 vaccine: Neutralizing activity against emerging variants retained
by Press Release from Outbreak News Today on (#5DA0Y)
Biotechnology company, Moderna Inc., today announced results from in vitro neutralization studies of sera from individuals vaccinated with Moderna COVID-19 Vaccine showing activity against emerging strains of SARS-CoV-2. Vaccination with the Moderna COVID-19 Vaccine produced neutralizing titers against all key emerging variants tested, including B.1.1.7 and B.1.351, first identified in the UK and Republic of South Africa, respectively. The [...]
The post Moderna COVID-19 vaccine: Neutralizing activity against emerging variants retained appeared first on Outbreak News Today.